Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - BRUKER CORP | a2231083zex-32_1.htm |
| EX-31.2 - EX-31.2 - BRUKER CORP | a2231083zex-31_2.htm |
| EX-31.1 - EX-31.1 - BRUKER CORP | a2231083zex-31_1.htm |
| EX-23.1 - EX-23.1 - BRUKER CORP | a2231083zex-23_1.htm |
| EX-21.1 - EX-21.1 - BRUKER CORP | a2231083zex-21_1.htm |
| EX-10.48 - EX-10.48 - BRUKER CORP | a2231083zex-10_48.htm |
| EX-4.1 - EX-4.1 - BRUKER CORP | a2231083zex-4_1.htm |
| 10-K - 10-K - BRUKER CORP | a2231083z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
- (1)
- Registration
Statement (Form S-8, No. 333-211686) pertaining to the Bruker Corporation 2016 Incentive Compensation Plan,
- (2)
- Registration
Statement (Form S-8, No. 333-167333) pertaining to the Bruker Corporation 2010 Incentive Compensation Plan,
- (3)
- Registration
Statement (Form S-3, No. 333-159982) and related Prospectus of Bruker Corporation for the registration of 70,000,000 shares of its common
stock, and
- (4)
- Registration Statements (Form S-8, Nos. 333-150430, 333-137090, 333-107294, and 333-47836) pertaining to the Bruker BioSciences Corporation Amended and Restated 2000 Stock Option Plan;
of our reports dated February 26, 2016, with respect to the consolidated financial statements of Bruker Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2016.
| |
|
|
|---|---|---|
| /s/ Ernst & Young LLP |
Boston,
Massachusetts
March 1, 2017
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM